BioCentury
ARTICLE | Financial News

Kala raises $6.2 million

March 15, 2012 1:12 AM UTC

Kala Pharmaceuticals Inc. (Waltham, Ma.) raised an additional $6.2 million in seed financing, bringing the total raised to $11.2 million. New investor Lighthouse Capital Partners joined existing investors Lux Capital; Polaris Venture Partners; and Third Rock Ventures.

Kala is using its mucus penetrating particle technology to develop treatments for diseases that affect mucosal tissues, including the respiratory tract, eye, GI tract and cervicovaginal tract. Kala said the technology achieves high, sustained local drug concentrations with reduced systemic exposure. ...